AbbVie profit beats estimates on higher Humira sales
January 30, 2015 at 08:04 AM EST
Jan 30 (Reuters) - U.S. drugmaker AbbVie Inc reported a better-than-expected quarterly adjusted profit due to higher sales of its autoimmune disease drug Humira.
